Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults

Clicks: 264
ID: 267088
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Evidence of active infection and suboptimal immunologic response during the first month of ART are associated with death in the first year after ART initiation in those with advanced HIV disease taking tuberculosis preventive therapy. Strategies to reduce early mortality in this population warrant f …
Reference Key
gp2017aidsrisk Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bisson GP;Ramchandani R;Miyahara S;Mngqibisa R;Matoga M;Ngongondo M;Samaneka W;Koech L;Naidoo K;Rassool M;Kirui F;Banda P;Mave V;Kadam D;Leger P;Henestroza G;Manabe YC;Bao J;Kumwenda J;Gupta A;Hosseinipour MC; ;;
Journal aids (london, england)
Year 2017
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/28742529
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support adult female male N.I.H. Extramural middle aged randomized controlled trials as topic risk factors hiv infections / complications* Survival Analysis hiv infections / drug therapy hiv infections / mortality* anti-retroviral agents / therapeutic use* pmid:28742529 pmc5633516 doi:10.1097/qad.0000000000001606 gregory p bisson ritesh ramchandani adult aids clinical trials group a5274 (remember) study team antitubercular agents / therapeutic use* coinfection / drug therapy coinfection / mortality* tuberculosis / complications* tuberculosis / drug therapy tuberculosis / mortality*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.